NCT06896071 Evaluating a Digital Single-session Intervention for Adolescent Mental Health in New Zealand
| NCT ID | NCT06896071 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Waikato |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-03-30 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-03-30 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Currently, one in five rangatahi (young people) in Aotearoa report difficulty accessing support for their mental health concerns. This treatment gap has prompted academics and clinicians to consider whether online and/or school-based interventions can increase access to evidence-based mental health care. This research is a randomised controlled trial to evaluate the effectiveness of Project SOLVE, an online problem-solving intervention, compared to Project Success, an activity that teaches young people study skills. Underdeveloped problem-solving skills have been associated with varying presentations of mental distress, including depression, hopelessness, and suicidal ideation. This association has meant problem solving is often featured as a core component of therapeutic interventions, and strengthening problem solving skills has been shown to improve clinical outcomes in youth who experience mental health concerns. For these reasons, the investigators hope that Project SOLVE will support the development of problem solving in rangatahi in Aotearoa and have a positive effect on their proximal and longitudinal mental health outcomes.
Eligibility Criteria
Inclusion Criteria: * Any Year 9 student (ages 12-14 years old) at a participating school who provides assent. Exclusion Criteria: * Any Year 9 student (ages 12-14 years old) at a participating school who does not provide assent and/or whose parent/caregiver does not provided consent.
Contact & Investigator
Morgan T Blind, BA(Hon)
PRINCIPAL INVESTIGATOR
University of Waikato
Frequently Asked Questions
Who can join the NCT06896071 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 14 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06896071 currently recruiting?
Yes, NCT06896071 is actively recruiting participants. Contact the research team at mb1080@students.waikato.ac.nz for enrollment information.
Where is the NCT06896071 trial being conducted?
This trial is being conducted at Cambridge, New Zealand.
Who is sponsoring the NCT06896071 clinical trial?
NCT06896071 is sponsored by The University of Waikato. The principal investigator is Morgan T Blind, BA(Hon) at University of Waikato. The trial plans to enroll 300 participants.